Polaryx Therapeutics Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 08/13/2026 | 1.66 M | $4.41 M | -0.03% | 3.43% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/12/2026 | 171.00 K | $455.08 K | 0.19% | 0.35% |
| VANGUARD FIDUCIARY TRUST CO | 08/13/2026 | 105.07 K | $279.49 K | 0.49% | 0.22% |
| HRT FINANCIAL LP | 08/14/2026 | 82.09 K | $218.00 K | 100.00% | 0.17% |
| STATE STREET CORP | 08/07/2026 | 58.10 K | $154.56 K | 0.00% | 0.12% |
| BLACKROCK, INC. | 08/07/2026 | 41.01 K | $109.09 K | 0.00% | 0.08% |
| JANE STREET GROUP, LLC | 08/14/2026 | 31.44 K | $83.63 K | 100.00% | 0.07% |
| NORTHERN TRUST CORP | 08/13/2026 | 27.99 K | $74.45 K | 0.00% | 0.06% |
| ALLWORTH FINANCIAL LP | 08/11/2026 | 7.73 K | $20.55 K | 100.00% | 0.02% |
| VANGUARD GLOBAL ADVISERS, LLC | 08/13/2026 | 6.32 K | $16.81 K | 0.00% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 08/11/2026 | 3.00 K | $7.99 K | 68.56% | 0.01% |
| UBS GROUP AG | 08/13/2026 | 1.28 K | $3.41 K | -90.48% | 0.00% |
| FORTITUDE FAMILY OFFICE, LLC | 07/20/2026 | 189 | $503 | 100.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| GOLDMAN SACHS GROUP INC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| MORGAN STANLEY | 08/13/2026 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
| SQUAREPOINT OPS LLC | 08/14/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Polaryx Therapeutics Inc. institutional Ownership - FAQ's
During the previous two years, 18 institutional investors and hedge funds held shares of Polaryx Therapeutics Inc.. The most heavily invested institutionals were:
VANGUARD CAPITAL MANAGEMENT LLC: 1.66 M
GEODE CAPITAL MANAGEMENT, LLC: 170,998
VANGUARD FIDUCIARY TRUST CO: 105,072
HRT FINANCIAL LP: 82,094
STATE STREET CORP: 58,104
BlackRock, Inc.: 41,012
4.54% of Polaryx Therapeutics Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 2.19 M shares in the last 24 months. This purchase volume represents approximately $7.72 M in transactions.